Young-Wolff Kelly C, Kline-Simon Andrea H, Das Smita, Mordecai Don J, Miller-Rosales Chris, Weisner Constance
Dr. Young-Wolff, Ms. Kline-Simon, Mr. Miller-Rosales, and Dr. Weisner are with the Division of Research, Kaiser Permanente, Oakland, California (e-mail:
Psychiatr Serv. 2016 Sep 1;67(9):996-1003. doi: 10.1176/appi.ps.201500337. Epub 2016 Apr 15.
Individuals with behavioral health conditions (BHCs) smoke at high rates and have limited success with quitting, despite impressive gains in recent decades in reducing the overall prevalence of smoking in the United States. This study examined smoking disparities among individuals with BHCs within an integrated health care delivery system with convenient access to tobacco treatments.
The sample consisted of patients in an integrated health care delivery system in 2010-a group (N=155,733) with one or more of the five most prevalent BHCs (depressive disorders, anxiety disorders, substance use disorders, bipolar and related disorders, and attention-deficit hyperactivity disorder) and a group (N=155,733) without BHCs who were matched on age, sex, and medical home facility. The odds of smoking among patients with BHCs versus without BHCs were examined over four years using logistic regression generalized estimating equation models. Tobacco cessation medication utilization among a subset of smokers in 2010 was also examined.
Although smoking prevalence decreased from 2010 to 2013 overall, the likelihood of smoking decreased significantly more slowly among patients with BHCs compared with patients without BHCs (p<.001), most notably among patients with substance use and bipolar and related disorders. Tobacco cessation medication use was low, and smokers with BHCs were more likely than smokers without BHCs to utilize these products (6.2% versus 3.6%, p<.001).
Smoking decreased more slowly among individuals with BHCs compared with individuals without BHCs, even within an integrated health care system, highlighting the need to prioritize smoking cessation within specialty behavioral health treatment.
尽管近几十年来美国吸烟总体患病率显著下降,但患有行为健康状况(BHCs)的人群吸烟率仍然很高,戒烟成功率也很低。本研究调查了在一个可便捷获得烟草治疗的综合医疗服务体系中,患有BHCs的个体之间的吸烟差异。
样本包括2010年一个综合医疗服务体系中的患者——一组(N = 155,733)患有五种最常见BHCs中的一种或多种(抑郁症、焦虑症、物质使用障碍、双相情感障碍及相关障碍、注意力缺陷多动障碍)的患者,以及一组(N = 155,733)无BHCs的患者,两组在年龄、性别和医疗之家机构方面进行了匹配。使用逻辑回归广义估计方程模型检查了四年中患有BHCs与无BHCs患者的吸烟几率。还调查了2010年一部分吸烟者的戒烟药物使用情况。
尽管总体吸烟率从2010年到2013年有所下降,但与无BHCs患者相比,患有BHCs患者的吸烟可能性下降得明显更慢(p <.001);在患有物质使用障碍以及双相情感障碍及相关障碍的患者中尤为明显。戒烟药物使用率较低,患有BHCs的吸烟者比无BHCs的吸烟者更有可能使用这些产品(6.2%对3.6%,p <.001)。
与无BHCs的个体相比,患有BHCs的个体吸烟率下降更慢,即使是在综合医疗体系内也是如此,这凸显了在专科行为健康治疗中优先考虑戒烟的必要性。